Average Co-Inventor Count = 13.05
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (12 from 2,405 patents)
2. Merck Canada Inc. (1 from 40 patents)
3. Merck Shapr & Dohme Corp. (1 from 1 patent)
13 patents:
1. 12331022 - Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors
2. 11332463 - Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors
3. 10870630 - Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors
4. 10072003 - Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use
5. 9994518 - Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof
6. 9868733 - Azabenzimidazole tetrahydrofuran derivatives
7. 9840481 - Allosteric modulators of nicotinic acetylcholine receptors
8. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives
9. 9540364 - Benzimidazole tetrahydrofuran derivatives
10. 9527839 - Benzimidazole tetrahydropyran derivatives
11. 9382243 - Azabenzimidazole tetrahydropyran derivatives
12. 9290517 - Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
13. 8796258 - Cyclic azabenzimidazole derivatives useful as anti-diabetic agents